A detailed history of Franklin Resources Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Franklin Resources Inc holds 536,447 shares of CYTK stock, worth $24.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
536,447
Previous 536,447 -0.0%
Holding current value
$24.6 Million
Previous $28.3 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$51.22 - $60.16 $6.81 Million - $7.99 Million
132,886 Added 32.93%
536,447 $28.3 Million
Q2 2024

Aug 14, 2024

SELL
$47.86 - $75.05 $7.74 Million - $12.1 Million
-161,735 Reduced 28.61%
403,561 $21.9 Million
Q1 2024

May 13, 2024

SELL
$63.75 - $108.06 $6.08 Million - $10.3 Million
-95,386 Reduced 14.44%
565,296 $39.6 Million
Q4 2023

Feb 09, 2024

SELL
$26.88 - $83.49 $12.6 Million - $39.3 Million
-470,406 Reduced 41.59%
660,682 $55.2 Million
Q3 2023

Nov 13, 2023

BUY
$29.46 - $36.61 $321,202 - $399,158
10,903 Added 0.97%
1,131,088 $33.3 Million
Q2 2023

Aug 11, 2023

BUY
$32.62 - $40.75 $1.16 Million - $1.45 Million
35,541 Added 3.28%
1,120,185 $36.5 Million
Q1 2023

May 12, 2023

SELL
$33.36 - $45.71 $713,770 - $978,011
-21,396 Reduced 1.93%
1,084,644 $38.2 Million
Q4 2022

Feb 10, 2023

SELL
$35.77 - $51.11 $79,838 - $114,077
-2,232 Reduced 0.2%
1,106,040 $50.7 Million
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $566,229 - $801,007
14,692 Added 1.34%
1,108,272 $53.7 Million
Q2 2022

Aug 11, 2022

BUY
$33.93 - $48.92 $57,952 - $83,555
1,708 Added 0.16%
1,093,580 $43 Million
Q1 2022

May 13, 2022

BUY
$29.74 - $46.0 $1.57 Million - $2.43 Million
52,799 Added 5.08%
1,091,872 $40.2 Million
Q4 2021

Feb 11, 2022

BUY
$34.35 - $46.38 $1.34 Million - $1.81 Million
39,026 Added 3.9%
1,039,073 $47.4 Million
Q3 2021

Nov 12, 2021

BUY
$18.54 - $35.74 $18.5 Million - $35.7 Million
1,000,047 New
1,000,047 $35.7 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.31B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.